Discontinued — last reported Q4 '25
Southern Company Interest Paid increased by 83.5% to $589.00M in Q3 2022 compared to the prior quarter. Year-over-year, this metric grew by 10.5%, from $533.00M to $589.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | |
|---|---|---|---|---|---|---|
| Value | $365.00M | $533.00M | $301.00M | $515.00M | $321.00M | $589.00M |
| QoQ Change | — | +46.0% | -43.5% | +71.1% | -37.7% | +83.5% |
| YoY Change | — | — | — | — | -12.1% | +10.5% |